There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Steris Corp (NYSE:STE) and ProQR (NASDAQ:PRQR) with bullish sentiments.
Steris Corp (STE)
KeyBanc analyst Matthew Mishan maintained a Buy rating on Steris Corp today and set a price target of $120. The company’s shares closed yesterday at $113.39, close to its 52-week high of $117.48.
According to TipRanks.com, Mishan is a 4-star analyst with an average return of 20.0% and a 82.2% success rate. Mishan covers the Healthcare sector, focusing on stocks such as Becton Dickinson, Cooper Co, and Hill-Rom.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Steris Corp with a $119.67 average price target, which is a 5.5% upside from current levels. In a report released yesterday, Stephens also reiterated a Buy rating on the stock with a $125 price target.
.
See today’s analyst top recommended stocks >>
ProQR (PRQR)
H.C. Wainwright analyst Andrew Fein maintained a Buy rating on ProQR today and set a price target of $20. The company’s shares closed yesterday at $7.45, close to its 52-week high of $7.50.
Fein observed:
“Our price target of $20/share is based on an equally-weighted composite of: (a) $21.3/share, as a 25x multiple of taxed and diluted $11.7 discounted back to FY18 at 30% (in line with the expected PE multiple and discount rate of an early development-stage biotechnology company); and (b) an NPV of $21.3/ share (discounted cash flow analysis using a 20% discount rate and 2.0% growth rate, in line with the expected discount and growth parameters of an early development-stage biotechnology company).”
According to TipRanks.com, Fein is a 3-star analyst with an average return of 2.5% and a 46.8% success rate. Fein covers the Healthcare sector, focusing on stocks such as Proteostasis Therapeutics Inc, ACADIA Pharmaceuticals Inc, and Strongbridge Biopharma Plc.
Currently, the analyst consensus on ProQR is a Moderate Buy with an average price target of $20.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
